Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,641 | 201 | 89.0% |
| Education | $450.40 | 4 | 11.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $537.88 | 7 | $0 (2024) |
| ABBVIE INC. | $346.80 | 25 | $0 (2024) |
| Abbott Laboratories | $281.17 | 13 | $0 (2024) |
| Medtronic USA, Inc. | $249.33 | 8 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $219.93 | 15 | $0 (2021) |
| Amgen Inc. | $215.37 | 9 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $210.55 | 8 | $0 (2020) |
| Daiichi Sankyo Inc. | $178.05 | 13 | $0 (2019) |
| PFIZER INC. | $169.49 | 9 | $0 (2024) |
| Purdue Pharma L.P. | $159.70 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $352.54 | 16 | ABBVIE INC. ($73.49) |
| 2023 | $159.77 | 7 | Abbott Laboratories ($55.21) |
| 2022 | $354.16 | 18 | Amgen Inc. ($116.46) |
| 2021 | $1,242 | 53 | Medtronic, Inc. ($515.72) |
| 2020 | $458.94 | 20 | Medtronic USA, Inc. ($226.52) |
| 2019 | $319.11 | 20 | Supernus Pharmaceuticals, Inc. ($61.19) |
| 2018 | $559.14 | 30 | Abbott Laboratories ($150.24) |
| 2017 | $646.40 | 41 | Purdue Pharma L.P. ($135.41) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| 11/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/04/2024 | ConvaTec Inc. | AQUACEL AG+ EXTRA (Device) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 10/17/2024 | Avanos Medical | GENERATOR (Device) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/29/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Analgesic | ||||||
| 08/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: PAIN | ||||||
| 07/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Analgesic | ||||||
| 05/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Opioid Analgesic | ||||||
| 03/25/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: PAIN | ||||||
| 03/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: PAIN | ||||||
| 03/15/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Neuromodulation | ||||||
| 03/15/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Neuromodulation | ||||||
| 01/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: PAIN | ||||||
| 10/16/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $15.14 | General |
| Category: non-opioid analgesic | ||||||
| 07/21/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: VACCINES | ||||||
| 07/17/2023 | Masimo Corporation | Patient SafetyNet System (Device) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/14/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $35.88 | General |
| Category: Neuromodulation | ||||||
| 06/15/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/03/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Neuromodulation | ||||||
| 12/31/2022 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Pain management | ||||||
| 10/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,444 | 3,304 | $1.8M | $238,376 |
| 2022 | 24 | 1,325 | 3,178 | $1.6M | $234,388 |
| 2021 | 22 | 1,334 | 3,227 | $1.8M | $248,811 |
| 2020 | 34 | 1,629 | 3,538 | $1.6M | $225,673 |
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 235 | 648 | $296,784 | $72,308 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 290 | 875 | $399,875 | $54,022 | 13.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 244 | 733 | $182,517 | $44,286 | 24.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 43 | 68 | $42,636 | $10,036 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 101 | $66,862 | $6,918 | 10.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 26 | 28 | $100,883 | $5,686 | 5.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 45 | 59 | $85,360 | $5,539 | 6.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 44 | 51 | $91,000 | $5,354 | 5.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $40,016 | $4,820 | 12.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 37 | 54 | $85,104 | $4,113 | 4.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 29 | 40 | $52,154 | $3,478 | 6.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 45 | 59 | $43,840 | $3,190 | 7.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 24 | 32 | $43,868 | $2,795 | 6.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 23 | 33 | $52,602 | $2,679 | 5.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 13 | 15 | $41,312 | $2,326 | 5.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 14 | 27 | $19,140 | $2,323 | 12.1% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 28 | 39 | $25,327 | $1,954 | 7.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 26 | 28 | $41,594 | $1,803 | 4.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 20 | $8,556 | $1,179 | 13.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 25 | 25 | $16,025 | $1,010 | 6.3% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 13 | 16 | $19,635 | $890.14 | 4.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 18 | $7,092 | $805.93 | 11.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 30 | 71 | $2,698 | $390.83 | 14.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 36 | $3,132 | $367.95 | 11.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 69 | $299.46 | $59.27 | 19.8% |
About Dr. Paul Mefferd, D.O
Dr. Paul Mefferd, D.O is a Pain Medicine healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1376755538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Mefferd, D.O has received a total of $4,092 in payments from pharmaceutical and medical device companies, with $352.54 received in 2024. These payments were reported across 205 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($3,641).
As a Medicare-enrolled provider, Mefferd has provided services to 5,732 Medicare beneficiaries, totaling 13,247 services with total Medicare billing of $947,248. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Marietta, GA
- Active Since 05/03/2007
- Last Updated 06/04/2025
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1376755538
Products in Payments
- SPECIFY (Device) $506.84
- NURTEC ODT (Drug) $252.10
- INTELLIS (Device) $229.93
- UBRELVY (Drug) $227.18
- TROKENDI XR (Drug) $210.55
- Aimovig (Biological) $196.80
- RELISTOR (Drug) $154.02
- Movantik (Drug) $152.49
- RELISTOR ORAL (Drug) $146.02
- Morphabond ER (Drug) $87.26
- SCS IPGs (Device) $83.74
- Proclaim Family of SCS IPGs (Device) $75.78
- AIMOVIG (Biological) $68.61
- QULIPTA (Drug) $68.57
- BELSOMRA (Drug) $64.64
- Horizant (Drug) $60.60
- HYSINGLA ER (Drug) $55.87
- PROCLAIM (Device) $55.21
- ORILISSA (Drug) $49.21
- Evzio (Drug) $48.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Marietta
Dr. Arnold Weil, M.d, M.D
Pain Medicine — Payments: $84,567
Donald Taylor, Md, MD
Pain Medicine — Payments: $11,293
Dr. Anthony Grasso, M.d, M.D
Pain Medicine — Payments: $5,463
Mr. Marc Kornfield, M.d, M.D
Pain Medicine — Payments: $3,678
Joseph Brown, Md, MD
Pain Medicine — Payments: $2,797
Charles Lee, Md, MD
Pain Medicine — Payments: $2,554